国内外卫生技术评估应用现状及对中医药的启示OACSTPCD

Since the United States first introduced the concept of health technology assessment(HTA)in 1976,countries have expanded their focus beyond the assessment of specific clinical treatment methods and means,instead utilizing HTA as a policy tool to judge the adoption and use of new technologies.As a tool to enhance the scientific,economic,and equitable nature of healthcare decision-making,the application of HTA in the field of traditional Chinese medicine(TCM)has been limited in terms of assessment scope,methods,and level of detail,with relatively slow development.By examining the organizational structures,assessment processes,and methodological characteristics of HTA in four European and American countries(the United Kingdom,Canada,Sweden,Germany)and five Asian countries(Japan,Korea,Thailand,Singapore,China),this paper aims to learn from the successful experiences of other countries and transform them into an HTA system that aligns with the unique features of TCM.This provides international practical experience for healthcare policy makers,researchers,and practitioners in China,thereby promoting the standardization,modernization,and internationalization of TCM.